“university-of-pennsylvania” Archives

in
Entry Author Date Location
Astellas Reports Third Patient Death in Audentes Gene Therapy Study 08/21/20 San Francisco
Pharma Partnering: Perspectives from Xcelerating Life Sciences Panel 06/16/20 Philadelphia
Biotech “Mapmaker” Immunai Launches With $20M to Chart the Immune System 05/14/20 New York
Passage Bio Plans IPO as Three Gene Therapies Approach the Clinic 02/03/20 New York
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More 11/08/19 National
Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More 11/01/19 National
Biogen’s Ehlers Leaving for Apple Tree, Steps Into Limelight as CEO 10/01/19 New York
Gilliland to Step Down as Head of Fred Hutch in 2020 09/17/19 Seattle
Advisory Body Backs Aimmune Peanut Allergy Drug, Next Up: the FDA 09/13/19 San Francisco
Amicus Offers First Look At Gene Therapy Work With Batten’s Data 08/01/19 New York
Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More 05/31/19 National
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More 04/19/19 National
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy 01/31/19 New York
Reuters Report Ranks U-M Among World’s Most Innovative Universities 10/12/18 Detroit Ann Arbor
Sarepta Touts New Data and a “Signal” With Duchenne Gene Therapy 10/03/18 Boston
Sarepta’s Data Are First in Rush for Duchenne Gene Therapy 06/19/18 Boston
With Acorda Data, Experts Weigh the Benefits of New Parkinson’s Drugs 04/25/18 New York
Novartis Bets $8.7B on AveXis’s Gene Therapy for Spine Disease 04/09/18 National
Solid Discloses More Problems As FDA Halts Duchenne Gene Therapy Study 03/14/18 Boston
Nonprofit Odylia Wants to Resurrect Stranded Gene Therapies 03/07/18 Boston
Bio Roundup: Wilson’s Warning, Amazon’s Health Biz, Moderna Cash & More 02/02/18 National
Avrobio Raises $60M for Fabry Disease Gene Therapy, Rest of Pipeline 02/01/18 Boston
After Paper Shakes Sector, Gene Therapy Leader Jim Wilson Talks Safety 01/30/18 National
Bio Roundup: Spark v. ICER, A Solid Revelation, T Cell Deals & More 01/26/18 National
Solid Discloses Duchenne Problems in IPO & Raises Rival’s Hackles 01/25/18 Boston
Tmunity Reels in $100M for “Next Generation” Cancer Immunotherapy 01/23/18 National
Juno Dissects ROCKET Deaths, Will Aim Better CAR-T at Leukemia 11/10/17 Seattle
Q&A: UW Prof on Whether Patient Portals Are Working as Designed 09/21/17 Wisconsin
RegenxBio to Acquire Dimension Tx in Combo of Gene Therapy Companies 08/25/17 Boston
Rubius Adds $120M to Ready Tests of Red Blood Cells as Drug Carriers 06/21/17 Boston
Page 1 of 4 next page »